Global Esomeprazole Market Opportunities and Forecast 2020-2027

  • DLR2896
  • 09 January, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Esomeprazole Market,By Type (Tablets,Capsules,Others), By Application(Gastroesophageal Reflux Disease (GERD),Stomach Ulcers,Others),and opportunities and forecast 2020-2027

Esomeprazole Market Overview

Increase within the cases of reflux sickness (GERD) because of excess acid production within the abdomen, like zollinger-ellison syndrome, might cause stomach ulcers or maybe abdomen cancer. Esomeprazole metallic element is employed throughout the beginning section of any reasonably excess acid issue within the abdomen to avoid any further serious consequences. These are a number of factors driving the world esomeprazole metallic element market.

Side-effects, like headache, diarrhoea, nausea or physiological reaction, constipation, abdomen pain or flatulence, may be a key issue restraining the world esomeprazole metallic element market. the majority WHO take esomeprazole seldom exhibit any side-effects. Side-effects square measure sometimes gentle and depart once the patient stops taking esomeprazole.

Prescription of esomeprazole metallic element in varied stomach-related issues that are caused because of acid reflux has created good chance for the world esomeprazole market.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Type,Application, and Region
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Alkem Laboratories Ltd.AstraZeneca plc.,Aurobindo Pharma Ltd.,Chongqing LUMMY Pharmaceutical Co., Ltd.,Dr. Reddy’s Laboratories Ltd.,Glenmark Pharmaceuticals Inc.,Grünenthal GmbH,Laboratorios Saval S.A.,Novartis AG (Sandoz),Sanofi SA,Stada Arzneimittel AG,Sun Pharmaceutical Industries Ltd.,Teva Pharmaceutical Industries Ltd.


The covid-19 Impact on Esomeprazole Market:

Whereas, the chemicals and accouterments sectors were relatively affected during the pandemic. This is primarily due to uncut demand for chemicals for healthcare, life wisdom, and drawing agents. However, other elements of chemical and material sectors such as types of paints, industrial oil, construction materials are facing reduction in demand. Strict lockdown reflected in a nearly 50-60% reduction in force for raw supply and availability, which directly affected the manufacturing process. Further, halt on numerous end-use diligence directly affected the chemical demand each around the world.
 
Esomeprazole market Segment Overview



By Type, Capsules segment is predicted to grow at a major rate within the Esomeprazole market. In 2019, Zydus Cadila received a delayed-release U.S. fda (Food & Drug Administration) approval to manufacture and market esomeprazole metal delayed – release capsules. it's used to treat the symptoms of reflux sickness, to reduce the danger of abdomen ulcers in some people taking pain medicines, to treat patients with a stomach infection (Helicobacter pylori).
 
By Application, Gastroesophageal reflux disease(GERD) accounted major market share,Increase within the cases of gastroesophageal reflux disease (GERD) due to excess acid production within the stomach, like zollinger-ellison syndrome, could cause stomach ulcer or maybe stomach cancer. Esomeprazole sodium is employed throughout the beginning part of any reasonably excess acid issue within the stomach to avoid are serious consequences.
 
Market Analysis, Insights and Forecast – By Type
·       Tablets
·       Capsules
·       Others

Market Analysis, Insights and Forecast – By Application
·       Gastroesophageal Reflux Disease (GERD)
·       Stomach Ulcers
·       Others

Esomeprazole Market Regional Overview

Region-wise, in terms of regions ,North America held a significant share of the worldwide esomeprazole sodium market. stomach in lifestyle and food habits has been a significant explanation for problems associated with abdomen acid among people within the region. Europe is anticipated to follow North America in terms of share of the worldwide Esomeprazole metallic element market. Incidence or prevalence of many gastrointestinal disorders has increased drastically in various countries across Europe, that has any fuelled the demand for esomeprazole sodium.

 Esomeprazole Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Esomeprazole Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Esomeprazole are highlighted below.

·       In 2020, Cipla received a United States of America FDA (Food & Drug Administration) to manufacture the generic version of Nexium. it's used for treating GERD, zollinger-ellison syndrome, reducing the chance of NSAIDS associated gastric ulcers, and H.pylori eradication. Thus, the aforementioned factors area unit expected to spice up the market.

Esomeprazole Market, Key Players -

·       Alkem Laboratories Ltd.
·       AstraZeneca plc
·       Aurobindo Pharma Ltd.
·       Chongqing LUMMY Pharmaceutical Co., Ltd.
·       Dr. Reddy’s Laboratories Ltd.
·       Glenmark Pharmaceuticals Inc.
·       Grünenthal GmbH
·       Laboratorios Saval S.A.
·       Novartis AG (Sandoz)
·       Sanofi SA
·       Stada Arzneimittel AG
·       Sun Pharmaceutical Industries Ltd.
·       Teva Pharmaceutical Industries Ltd.
 

Frequently Asked Questions (FAQ) :

Q1. What is the total CAGR expected to be recorded for the Esomeprazole Market during the forecast period?

A. Esomeprazole market is expected to record a CAGR of ~ XX % during the forecast period.

Q2. Which segment is projected to hold the largest share in the Esomeprazole Market?

A. Capsule segment is projected to hold the largest share in the Esomeprazole Market

Q3. What are the driving factors for the Esomeprazole Market?

A. Increase in the cases of gastroesophageal reflux disease (GERD) due to excess acid production in the stomach and the growing variety of pipeline studies , these are main factors driving the growth of automotive lighting market

Q4. Which Segments are covered in the Esomeprazole Market report?

A. Type , Application and Region, these segments are covered in the Esomeprazole Market report.

Q5. Which are the prominent players offering Esomeprazole Market?

A. Alkem Laboratories Ltd.,AstraZeneca plc.,Aurobindo Pharma Ltd.,Chongqing LUMMY Pharmaceutical Co., Ltd.,Dr. Reddy’s Laboratories Ltd.,Glenmark Pharmaceuticals Inc.,Grünenthal GmbH,Laboratorios Saval S.A.,Novartis AG (Sandoz),Sanofi SA,Stada Arzneimittel AG,Sun Pharmaceutical Industries Ltd.,Teva Pharmaceutical Industries Ltd.
Esomeprazole Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Esomeprazole Market analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Type
        • 5.2.1. •Tablets
        • 5.2.2. •Capsules
        • 5.2.3. •Others
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Gastroesophageal Reflux Disease (GERD)
        • 5.3.2. •Stomach Ulcers
        • 5.3.3. •Others
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East, and Africa

      6. North America Esomeprazole Market Analysis(USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Type
        • 6.2.1. •Tablets
        • 6.2.2. •Capsules
        • 6.2.3. •Others
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Gastroesophageal Reflux Disease (GERD)
        • 6.3.2. •Stomach Ulcers
        • 6.3.3. •Others
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. UK
        • 6.4.2. Germany
        • 6.4.3. France
        • 6.4.4. Italy
        • 6.4.5. Spain
        • 6.4.6. Russia
        • 6.4.7. Rest of Europe

      7. Asia Pacific Esomeprazole Market Analysis(USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Type
        • 7.2.1. •Tablets
        • 7.2.2. •Capsules
        • 7.2.3. •Others
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Gastroesophageal Reflux Disease (GERD)
        • 7.3.2. •Stomach Ulcers
        • 7.3.3. •Others
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. China
        • 7.4.2. India
        • 7.4.3. Japan
        • 7.4.4. Australia
        • 7.4.5. South East Asia
        • 7.4.6. Rest of Asia Pacific

      8. Latin America, Middle East, and Africa Esomeprazole Market Analysis(USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Type
        • 8.2.1. •Tablets
        • 8.2.2. •Capsules
        • 8.2.3. •Others
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Gastroesophageal Reflux Disease (GERD)
        • 8.3.2. •Stomach Ulcers
        • 8.3.3. •Others
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. Brazil
        • 8.4.2. Saudi Arabia
        • 8.4.3. UAE
        • 8.4.4. Rest of LAMEA

      9. Competitive Analysis

      • 9.1. Company Market Share Analysis, 2018
      • 9.2. Key Industry Developments
      • 9.3. Company Profile
      • 9.4. Alkem Laboratories Ltd.
        • 9.4.1. Business Overview
        • 9.4.2. Segment 1 & Service Offering
        • 9.4.3. Overall Revenue
        • 9.4.4. Geographic Presence
        • 9.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 9.5. •AstraZeneca plc
      • 9.6. •Aurobindo Pharma Ltd.
      • 9.7. •Chongqing LUMMY Pharmaceutical Co., Ltd.
      • 9.8. •Dr. Reddy’s Laboratories Ltd.
      • 9.9. •Glenmark Pharmaceuticals Inc.
      • 9.10. •Grünenthal GmbH
      • 9.11. •Laboratorios Saval S.A.
      • 9.12. •Novartis AG (Sandoz)
      • 9.13. •Sanofi SA
      • 9.14. •Stada Arzneimittel AG
      • 9.15. •Sun Pharmaceutical Industries Ltd.

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934